What is KZR stock price today?

KZR (Kezar Life Sciences Inc) stock is trading at $7.37 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is KZR stock going up or down today?

KZR stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy KZR stock now?

The decision to buy KZR depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is KZR a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for KZR based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is KZR stock overvalued or undervalued?

Use our DCF valuation calculator to determine if KZR is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is KZR's P/E ratio?

P/E ratio data for KZR will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is KZR's market cap?

KZR (Kezar Life Sciences Inc) has a market capitalization of $0.05 billion, making it a small-cap stock.

What is KZR's price to book ratio?

KZR trades at a price-to-book (P/B) ratio of 0.78, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does KZR pay dividends?

KZR does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is KZR's dividend yield?

KZR does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is KZR stock a good long-term investment?

KZR's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is KZR's revenue growth rate?

Revenue growth data for KZR is available on our dashboard with detailed financial statement analysis.

Profitability metrics for KZR are available on our dashboard with complete income statement analysis.

What are the risks of investing in KZR?

Key risks for KZR include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does KZR compare to its competitors?

Compare KZR to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize KZR's performance and positioning.

What is KZR's stock price target for 2026?

Our AI model provides price targets for KZR based on fundamental analysis: Bull case $9.58 (+30%), Base case $8.48 (+15%), Bear case $6.63 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about KZR?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for KZR. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is KZR's next earnings report?

KZR reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

KZR - Kezar Life Sciences Inc

NYSE * Health Care * Biotechnology

$7.37

$-0.01 (-0.14%)

About Kezar Life Sciences Inc

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

KZR Key Statistics

Market Cap

$54.40M

P/B Ratio

0.78

EPS

$-7.66

Employees

How KZR Compares to Peers

KZR is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
KZR(This stock)	$54.40M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.34B	24.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$171.97B	20.4	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$110.81B	28.4	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$78.87B	18.0	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.03B	20.0	-0%	0.1%	vs BIIB

Kezar Life Sciences Inc Company Information

Headquarters: California; U.S.A
Website: www.kezarlifesciences.com
Sector: Health Care
Industry: Biotechnology

Data Updated: April 18, 2026 at 6:28 AM EDT

Ready to invest in KZR?

Commission-free trading available. Affiliate links.

KZR Lician Score

5% confidence

4.0/10

Neutral

KZR has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates KZRacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

KZR Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for KZR

Dashboard

Enter a ticker to analyze